Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
about
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virusThe CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population.The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations.Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy.Staphylococcus aureus and CCR5: unveiling commonalities in host-pathogen interactions and potential treatment strategies.Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198.RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4⁺ T-Cells.CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy.CCR5-Delta32: implications in SLE development.
P2860
Q26797870-479D4DC9-763A-428B-9F90-7BE9EC97F57EQ30377320-4E761F0B-23B2-44EF-9727-4C167B2B8F6AQ35630456-406C7EE3-75F7-4425-97C2-AC8D14C2A32CQ35837709-2E39DC38-4049-4328-978B-64797190EA6FQ37411605-8D220A05-F44D-41F8-BDE9-5CE5EC02A09DQ39444359-F1F17FBD-0BC1-4BA0-BA76-4FE47329064CQ39944975-440B7CF3-DD13-4FC3-A02A-3C96ECA2A053Q42487076-46EB6931-0402-4752-AD9E-C8FE92E130A0Q47107303-6196EF8A-770C-40EB-92A5-F966D82D5EC2Q48104606-0B3A911D-0685-48E3-AAB7-6A4634AAE597Q51016561-DE365E4E-3606-410E-96CE-5A454B6B74E6Q52718314-67CCAF9C-51A3-489C-BF1E-3B0873BE2A98Q54688004-50172AC3-42D9-4E5C-B85A-5A69C08855CA
P2860
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
@en
type
label
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
@en
prefLabel
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
@en
P2093
P2860
P1433
P1476
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?
@en
P2093
Derek Kennedy
Gholamhossein Hassanshahi
Khodayar Ghorban
Maryam Dadmanesh
Mohammad Kazemi Arababadi
Mohammad Momeni
Mohammad Zare-Bidaki
P2860
P2888
P304
P356
10.1007/S10753-012-9585-8
P577
2013-06-01T00:00:00Z
P6179
1025349648